(Q33236751)

English

Metabolic risk factor profile associated with use of second generation antipsychotics: a cross sectional study in a Community Mental Health Centre

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Metabolic risk factor profile associated with use of second generation antipsychotics: a cross sectional study in a Community Mental Health Centre (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

0 references

0 references

community mental health

1 reference

based on heuristic

inferred from title

Ilaria Tarricone

object named as

Ilaria Tarricone

1

0 references

Alessandro Serretti

object named as

Alessandro Serretti

6

0 references

author name string

Michela Casoria

2

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Beatrice Ferrari Gozzi

3

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Daniela Grieco

4

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Marco Menchetti

5

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Manjola Ujkaj

7

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Francesca Pastorelli

8

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Domenico Berardi

9

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

16 March 2006

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435746

21 June 2018

Modern antipsychotic drugs: a critical overview

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435746

21 June 2018

Clozapine, risperidone, olanzapine, and conventional antipsychotic drug effects on glucose, lipids, and leptin in schizophrenic patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435746

21 June 2018

Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435746

21 June 2018

Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435746

21 June 2018

Diabetes, psychotic disorders and antipsychotic therapy: a consensus statement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435746

21 June 2018

Increasing prevalence of the metabolic syndrome among u.s. Adults.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435746

21 June 2018

Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435746

21 June 2018

The effects of antipsychotic therapy on serum lipids: a comprehensive review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435746

21 June 2018

Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435746

21 June 2018

'Schizophrenia and Diabetes 2003' Expert Consensus Meeting, Dublin, 3-4 October 2003: consensus summary.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435746

21 June 2018

Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435746

21 June 2018

A prospective study of impairment in glucose control caused by clozapine without changes in insulin resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435746

21 June 2018

Consensus development conference on antipsychotic drugs and obesity and diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435746

21 June 2018

Schizophrenia and weight management: a systematic review of interventions to control weight.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435746

21 June 2018

Differential effects of antipsychotic agents on the risk of development of type 2 diabetes mellitus in patients with mood disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435746

21 June 2018

A meta-analysis of the efficacy of second-generation antipsychotics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435746

21 June 2018

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435746

21 June 2018

Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435746

21 June 2018

Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435746

21 June 2018

Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435746

21 June 2018

Hyperglycemia and antipsychotic medications.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435746

21 June 2018

Glucose metabolism in relation to schizophrenia and antipsychotic drug treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435746

21 June 2018

Antipsychotic-induced weight gain: a comprehensive research synthesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435746

21 June 2018

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435746

21 June 2018

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435746

21 June 2018

Old versus new: weighing the evidence between the first- and second-generation antipsychotics.

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-6-11

21 January 2018

Novel antipsychotics and severe hyperlipidemia

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-6-11

21 January 2018

Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-6-11

21 January 2018

An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-6-11

21 January 2018

Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-6-11

21 January 2018

Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-6-11

21 January 2018

Weight changes during clozapine treatment

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-6-11

21 January 2018

Weight gain with clozapine compared to first generation antipsychotic medications

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-6-11

21 January 2018

Olanzapine versus risperidone: weight gain and elevation of serum triglyceride levels

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-6-11

21 January 2018

Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-6-11

21 January 2018

Polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-6-11

21 January 2018

Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-6-11

21 January 2018

The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-6-11

21 January 2018

Changes in body mass index for individuals with and without schizophrenia, 1987–1996

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-6-11

21 January 2018

Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435746

31 October 2018

Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435746

31 October 2018

Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435746

31 October 2018

Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435746

31 October 2018

Weight gain induced by clozapine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1435746

31 October 2018

Body mass index in persons with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16542430

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/16542430

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-244X-6-11

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Dimensions Publication ID

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-244x-6-11

9 September 2019

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33236751&oldid=2195158468"